Mozambique vs Zimbabwe: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Mozambique
- Zimbabwe
How they compare
Mozambique currently reports 120,359 deaths against 84,960 deaths in Zimbabwe, a difference of 35,399 deaths.
That makes Mozambique's figure about 1.4 times Zimbabwe's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Zimbabwe ahead.
Mozambique ranks 2nd and Zimbabwe ranks 5th of 157 countries.
Across the 4 decades both report, Mozambique averaged higher in 1 and Zimbabwe in 3.
Head to head by decade
| Decade | Mozambique | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 275.56 deaths | 275.56 deaths | Zimbabwe |
| 2000s | 9,043 deaths | 11,375 deaths | 2,332 deaths | Zimbabwe |
| 2010s | 68,348 deaths | 75,537 deaths | 7,188 deaths | Zimbabwe |
| 2020s | 111,036 deaths | 86,746 deaths | 24,290 deaths | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Mozambique or Zimbabwe?
- Mozambique, at 120,359 deaths against 84,960 deaths in Zimbabwe as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Mozambique and Zimbabwe?
- 35,399 deaths, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Zimbabwe?
- 35 years are reported by both, from 1990 to 2024.
- How do Mozambique and Zimbabwe rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Mozambique ranks 2nd and Zimbabwe ranks 5th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.